ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1948

The Mechanism of DC-STAMP-Mediated Signaling in Cell-Cell Fusion and Osteoclast Maturation

Ananta Paine1, Kerstin Tiedemann 2, Maria de la luz Garcia-Hernandez 1, Svetlana Komarova 2 and Christopher Ritchlin 1, 1Division of Allergy, Immunology and Rheumatology, Center for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA, Rochester, NY, 2Faculty of Dentistry, McGill University, Montreal, Quebec, Canada; Shriners Hospital for Children-Canada, Montreal, Quebec, Canada, Montréal, QC, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: calcium signaling, cell-cell fusion and RNAseq, DCSTAMP, osteoclastogenesis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Genetics, Genomics & Proteomics Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoclasts (OC) are bone-resorbing, multinuclear cells that originate from myeloid progenitor cells through repetitive cycles of cell-cell fusion. Dendritic cell-specific transmembrane protein (DC-STAMP) is essential for cell-cell fusion and formation of fully functional OC, resulting in mild-moderate osteopetrosis in DC-STAMP-/- mice; however the molecular mechanisms of its action is not well understood. We examined how the complete absence of DC-STAMP in the osteogenic progenitor cells (OCPs) affects their ability to participate in cell-cell fusion, alters calcium (Ca2+) signaling, and gene and protein expression in response to osteoclastogenic stimuli: macrophage colony-stimulating factor (MCSF) and  receptor activator of nuclear factor kappa-B ligand (RANKL).

Methods: We isolated bone marrow macrophages (BMMs) from wild type (WT) and DC-STAMP knockout (KO) mice. To analyze cell-cell fusion, we labeled DCSTAMP+/+ and DCSTAMP-/- BMMs with red (CellVue® Red) and green (CellVue® Jade) membrane dyes respectively, cultured them with MCSF (30 – 50 ng/ml) and RANKL (30 – 50 ng/ml) and monitored cell-cell fusion with live cell imaging. Calcium signaling was examined using microspectrofluorimetry of Fura-2 loaded OC precursors. Activation of osteoclastogenic transcription factor NFATc1 was assessed using immunoblotting and immunofluorescence. The effect of DC-STAMP knockout on gene and protein expression was examined using RNAseq, quantitative PCR (qPCR), and immunoblotting.

Results: DCSTAMP+/+ cells were essential to initiate cell-cell fusion events; however DC-STAMP-/- BMMs were successfully incorporated into forming OC. RANKL-induced Ca2+ oscillations were still present in DC-STAMP-/- precursors, and increased in intensity compared to DC-STAMP+/+ OCPs during the later stages of differentiation. NFATc1 protein levels in DCSTAMP-/- OCPs increased with time following RANKL exposure and were comparable to WT. However, nuclear translocation of NFATc1 was significantly decreased in DCSTAMP-/- osteoclast precursors at day 3 of differentiation. We further observed decreased expression of key osteoclastogenic genes (CTSK, ATP6V0D2, ACP5) in DCSTAMP-/- cells. RNAseq analysis of DCSTAMP-/- and WT OCPs identified differentially expressed genes indicating alterations in key molecular pathways, including RELA, NFκB, FOS, PKC, and TREM1 signaling.

Conclusion: Our findings indicate that while DC-STAMP-/- OCPs cannot form multinuclear OCs, they do fuse with DCSTAMP+/+ OCPs and are incorporated into maturing OCs. We demonstrate that even though calcium oscillations are present in DC-STAMP-/- OCPs, NFATc1 nuclear translocation is deficient, suggesting that DC-STAMP acts in the  NFATc1 pathway, but downstream of calcium signaling. Our RNAseq analysis identified multiple differentially expressed genes that are potentially involved in cell-cell fusion and maturation of OCs.


Disclosure: A. Paine, None; K. Tiedemann, None; M. Garcia-Hernandez, None; S. Komarova, None; C. Ritchlin, AbbVie, 2, 5, 9, Amgen, 2, 5, BMS, 5, Janssen, 5, Janssen Research & Development, LLC, 2, Lilly, 5, Novartis, 5, Pfizer, 2, Pfizer Inc, 5, UCB, 2, 5.

To cite this abstract in AMA style:

Paine A, Tiedemann K, Garcia-Hernandez M, Komarova S, Ritchlin C. The Mechanism of DC-STAMP-Mediated Signaling in Cell-Cell Fusion and Osteoclast Maturation [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-mechanism-of-dc-stamp-mediated-signaling-in-cell-cell-fusion-and-osteoclast-maturation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-mechanism-of-dc-stamp-mediated-signaling-in-cell-cell-fusion-and-osteoclast-maturation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology